Skip to content

Perrigo Company plc (PRGO) Company Overview

Company Analysis

Perrigo Company plc PRGO

A comprehensive view of key metrics, scores, and financial health for Perrigo Company plc

Overview of Perrigo Company plc

PRGO NYQ
Healthcare Drug Manufacturers - Specialty & Generic Small Cap
Perrigo Company plc (PRGO), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $9.30, about 397.4% undervalued vs fair value, -67.1% 1Y return, ranked 360/1110 in sector.
$9.30
-1.27%
As of March 13, 2026
Previous close • Vol 90d: 61.9%
Market Cap
$1.48B
Enterprise Value
$980.60M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Perrigo Company plc.

Top Beats

Quick Facts

HQ Dublin
Employees 8,100
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$41
$46
$52
Current: $9.30 +397% vs base

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$4.3B
-2.8%%
Gross Profit
$1.5B
-3.1%%
R&D Expense
$95.4M
-15%%
Operating Income (EBIT)
$-1.1B
-1160.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
2.2%
Fair

Lower R&D intensity - may indicate mature portfolio or cost cuts

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$159.3M
65.1% of FCF

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
4
Active Leaks
0/4
Improving
0
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Perrigo Company plc's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
47
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
39
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing PRGO's balance between Growth (19.0%), Profitability (35.7%), and Safety (45.3%). Growth 19% Safety 45% Profitability 36%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

24th percentile vs peers
24
Key Signals
Rev Growth YoY -2.8% 27p Revenue CAGR 3Y -1.5% 31p TSR -41.4% 41p EPS Growth YoY -12.32 2p
  • Superior capital returns - 2 return metrics above peer median
  • Net Debt/Ebitda in top 20% of peers (7.07, 82th percentile)
  • Debt/Fcf Ratio in top 20% of peers (14.79, 92th percentile)
  • Conservative leverage compared to industry peers
  • Eps Growth Yoy in bottom 20% of peers (-12.32)

Profitability

45th percentile vs peers
46
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

58th percentile vs peers
58
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Perrigo Company plc.

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$46.26
- - -
+397.4% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info